CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Electric-Acoustic Stimulation (EAS) Cochlear Implant Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03031678
NCT03031678N/ACompleted
CompareCT.gov

Office of Device Evaluation Lead-MED-EL EAS Extended f/u Study

Med-El Corporation·interventional·Posted Jan 25, 2017·Updated Sep 10, 2020

In Brief

A clinical study evaluating Electric-Acoustic Stimulation (EAS) Cochlear Implant System for Hearing Loss, Sensorineural. Completed, enrolled 50 participants across 7 sites.

Detailed Summary

The MED-EL EAS Extended Follow-up Study is an extended follow-up of the subjects who were enrolled in the pivotal study to assess long-term safety and device performance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Sensorineural
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 25, 2017
Enrollment StartDec 1, 2016
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 9.4 years ago

Interventions

Electric-Acoustic Stimulation (EAS) Cochlear Implant Systemdevice

Combination of a cochlear implant and a hearing aid